Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viatris Inc (VTRS)

Viatris Inc (VTRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,093,656
  • Shares Outstanding, K 1,164,418
  • Annual Sales, $ 14,300 M
  • Annual Income, $ -3,515 M
  • EBIT $ 274 M
  • EBITDA $ 6,009 M
  • 60-Month Beta 0.83
  • Price/Sales 1.14
  • Price/Cash Flow 1.90
  • Price/Book 1.10

Options Overview Details

View History
  • Implied Volatility 39.09% (-0.72%)
  • Historical Volatility 29.12%
  • IV Percentile 52%
  • IV Rank 41.11%
  • IV High 57.21% on 04/21/25
  • IV Low 26.44% on 12/23/25
  • Expected Move (DTE 25) 1.11 (7.53%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 4,202
  • Volume Avg (30-Day) 1,587
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 184,938
  • Open Int (30-Day) 180,929
  • Expected Range 13.58 to 15.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.52
  • Number of Estimates 4
  • High Estimate $0.56
  • Low Estimate $0.49
  • Prior Year $0.50
  • Growth Rate Est. (year over year) +4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.87 +14.06%
on 03/30/26
14.74 -0.41%
on 04/17/26
+0.88 (+6.38%)
since 03/17/26
3-Month
12.55 +17.02%
on 01/20/26
16.47 -10.87%
on 02/26/26
+1.82 (+14.15%)
since 01/16/26
52-Week
7.47 +96.65%
on 04/21/25
16.47 -10.87%
on 02/26/26
+7.12 (+94.18%)
since 04/17/25

Most Recent Stories

More News
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know

Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know

NTRA : 208.40 (+6.27%)
UFPT : 202.38 (+4.30%)
VTRS : 14.68 (+4.78%)
MTD : 1,340.58 (+3.85%)
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026

PITTSBURGH , April 13, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report first quarter 2026 financial results on Thursday, May 7, 2026....

VTRS : 14.68 (+4.78%)
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

PITTSBURGH , April 10, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that four abstracts will be presented at the American Society of Cataract...

VTRS : 14.68 (+4.78%)
Viatris Stock: Is VTRS Outperforming the Health Care Sector?

As Viatris has outperformed the broader health care sector over the past year, and analysts remain moderately optimistic about the stock’s prospects.

XLV : 148.80 (+1.49%)
VTRS : 14.68 (+4.78%)
TEVA : 32.40 (+3.65%)
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

Addresses a Significant Unmet Need in Japan as First and Only Approved Treatment Option for GAD

VTRS : 14.68 (+4.78%)
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030

PITTSBURGH , March 19, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) will host its Investor Event today, where members of the executive leadership team will outline the Company's strategic...

VTRS : 14.68 (+4.78%)
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm

1 Cash-Producing Stock to Target This Week and 2 That Underwhelm

GMED : 95.25 (+2.68%)
VTRS : 14.68 (+4.78%)
CPNG : 21.55 (+0.28%)
Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings?

Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings?

VTRS : 14.68 (+4.78%)
Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4

Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4

VTRS : 14.68 (+4.78%)
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025

Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025

VTRS : 14.68 (+4.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor...

See More

Key Turning Points

3rd Resistance Point 15.61
2nd Resistance Point 15.17
1st Resistance Point 14.93
Last Price 14.68
1st Support Level 14.25
2nd Support Level 13.81
3rd Support Level 13.57

See More

52-Week High 16.47
Last Price 14.68
Fibonacci 61.8% 13.03
Fibonacci 50% 11.97
Fibonacci 38.2% 10.90
52-Week Low 7.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.